Dosage Charts Calculator Blends & Stacks Learn Blog Peptides
Open Calculator
Blog  ›  LL-37: The Body's Own Antibiotic Peptide Explained

LL-37: The Body's Own Antibiotic Peptide Explained

Jun 11, 2026 4 min Immune
TL;DR
LL-37 is a natural human peptide that acts like a built-in antibiotic and immune regulator. Researchers are studying it for infections, wound healing, heart disease, and oral health. Evidence is promising but mostly preclinical — human trials are still limited.

What Exactly Is LL-37?

Your immune system keeps a secret weapon tucked inside certain white blood cells and skin cells: a small protein called LL-37. The name comes from its shape — it has 37 building blocks (amino acids), and the first two are both leucine, a type of amino acid abbreviated as "L."

LL-37 belongs to a family of molecules called cathelicidins. Think of cathelicidins as nature's own antibiotics. They punch holes in the membranes of bacteria, essentially popping them like balloons. LL-37 is the only cathelicidin that humans naturally produce.[2]

Its shape matters a lot. Scientists describe it as amphipathic — one side of the molecule likes water, the other repels it. That split personality lets it wedge itself into bacterial cell walls and disrupt them.[6]

More Than Just an Antibiotic

Early researchers focused on LL-37's germ-killing power. But it turns out this peptide wears many hats.

  • Immune modulator: LL-37 doesn't just kill bacteria — it also tells the immune system how to respond. It can dial inflammation up or down depending on what the body needs.[2]
  • Wound healer: It encourages new blood vessels to form (a process called angiogenesis) and nudges stem cells to migrate toward damaged tissue.[1]
  • Biofilm buster: Bacteria often hide in sticky communities called biofilms — think plaque on teeth. LL-37 can break up those communities in lab studies.[3]
  • NETosis trigger: Neutrophils (a type of white blood cell) can release sticky nets of DNA to trap pathogens. LL-37 helps trigger this process, called NETosis.[6]

What Are Scientists Studying It For?

Fighting Stubborn Infections

Antibiotic resistance is a global crisis. Bacteria that ignore conventional drugs often shelter in biofilms, making them even harder to kill. Lab research shows LL-37 can disrupt biofilms formed by dangerous pathogens including Staphylococcus aureus, Pseudomonas aeruginosa, and E. coli.[3] It does this by blocking bacterial adhesion, jamming their communication signals (quorum sensing), and degrading the sticky matrix the biofilm lives in.[3]

Oral and Bone Health

Your saliva and gum tissue naturally contain LL-37. Researchers at the University of Pennsylvania found it plays a key role in periodontal (gum) and bone regeneration — stimulating stem cells and promoting the growth of new blood vessels that supply nutrients to healing tissue.[1] A separate review confirmed that oral LL-37 levels are linked to both protection against infection and the severity of gum disease.[5]

Heart Disease

A 2024 review highlighted LL-37's surprisingly complex role in cardiovascular health.[4] On one hand, it may help regulate atherosclerosis (hardening of the arteries) and reduce harmful inflammation. On the other hand, at high concentrations it could promote certain clotting processes. Researchers are working to understand that balance — and whether engineered versions of LL-37 could be designed to capture the benefits without the risks.[4]

Immune Regulation

Because LL-37 sits at the crossroads of innate immunity, scientists are studying whether low levels of it contribute to conditions like chronic infections or poor wound healing, while abnormally high levels might drive autoimmune problems.[5] Its fragments — smaller pieces like FK-13 and LL-37 sub-domains — appear to interact with specific immune receptors, giving researchers potential targets for new therapies.[2]

What Does the Evidence Actually Show?

Be clear-eyed here. Most LL-37 research is preclinical — meaning lab dishes and animal models. That's important groundwork, but it doesn't automatically translate to humans. Human clinical trials are still in early stages for most applications.

What researchers do agree on: LL-37 is a genuinely multifunctional molecule with real biological activity. Its antimicrobial and immunomodulatory effects are well-documented in the lab.[3][2] Its role in tissue repair is biologically plausible and supported by preclinical data.[1] Its cardiovascular story is more complicated and needs more study.[4]

This is a fast-moving field. New engineered analogs — modified versions designed to be more stable or targeted — are already being developed and tested.[4]

Curious About Dosage Data?

If you're researching LL-37 for scientific or educational purposes, our LL-37 dosage chart compiles data from published studies in one easy reference. You can also use the calculator to explore how researchers have scaled doses across different experimental models. As always, this information is strictly for research and educational use — not medical advice.

Sources

  1. Regulation of LL-37 in Bone and Periodontium Regeneration. — Life (Basel, Switzerland), 2022. PMID 36294968.
  2. The LL-37 domain: A clue to cathelicidin immunomodulatory response? — Peptides, 2023. PMID 37068711.
  3. Antibiofilm properties of cathelicidin LL-37: an in-depth review. — World journal of microbiology & biotechnology, 2023. PMID 36781570.
  4. Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease. — Pharmacological research, 2024. PMID 39615616.
  5. Cathelicidin LL-37 in Health and Diseases of the Oral Cavity. — Biomedicines, 2022. PMID 35625823.
  6. LL-37, a Multi-Faceted Amphipathic Peptide Involved in NETosis. — Cells, 2022. PMID 35954305.
See the dosage chart — LL-37
An antimicrobial host-defense peptide studied for immune modulation.
LL-37

FAQ

What is LL-37 made from?
LL-37 is a fragment of a larger protein called hCAP-18, which is stored inside immune cells and certain skin and mucosal cells. When the body senses a threat — like bacteria — hCAP-18 gets cleaved (cut) by enzymes, releasing the active LL-37 peptide. It is the only cathelicidin peptide naturally produced by humans.[2]
Can LL-37 fight antibiotic-resistant bacteria?
Lab studies show LL-37 can disrupt biofilms and kill several antibiotic-resistant bacterial species including Staphylococcus aureus and Pseudomonas aeruginosa. It works through multiple mechanisms — breaking up the biofilm matrix, jamming bacterial communication, and destroying cell membranes — making resistance harder to develop. However, in vivo (living organism) evidence is still limited.[3]
Is LL-37 involved in any diseases?
Yes — both too little and too much LL-37 can be problematic. Low levels are linked to increased infection risk and poor wound healing. Elevated levels have been associated with inflammatory and autoimmune conditions. Researchers are also investigating its dual role in heart disease, where it may help regulate atherosclerosis but could complicate clotting under certain conditions.[4][5]
Where can I find LL-37 dosage information used in research?
Our dedicated LL-37 dosage chart summarizes dose ranges reported in published peer-reviewed studies. For cross-model comparisons, use the calculator. All data is compiled for research and educational reference only and does not constitute medical or clinical guidance.
For research and educational use only. Not medical advice.